Clinical Trial Update: Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating whether low-dose aspirin can prevent new or recurrent colorectal adenomas in people with Lynch syndrome; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma
• Lynch Syndrome

Drugs mentioned

• Aspirin (low-dose) (acetylsalicylic acid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lynch Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING